| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |